Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance

Y. Obitsu, T. Ohta, M. Ando, H. Shigematsu, T. Miyata, T. Kawasaki, A. Ishida, A. Ishida, T. Yasugi, K. Matsuzaki, K. Hida, T. Nishibe, T. Nishibe, S. Shindo, S. Shindo, T. Matsumoto, Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD). International Angiology. ,vol. 29, pp. 2- 13 ,(2010)

MICHIEL P. DE BOER, RICK I. MEIJER, NIENKE J. WIJNSTOK, AMY M. JONK, ALPHONS J. HOUBEN, COEN D. STEHOUWER, YVO M. SMULDERS, ETTO C. ERINGA, ERIK H. SERNÉ, Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation. ,vol. 19, pp. 5- 18 ,(2012) , 10.1111/J.1549-8719.2011.00130.X

Tetsuya Kubota, Naoto Kubota, Hiroki Kumagai, Shinichi Yamaguchi, Hideki Kozono, Takehiro Takahashi, Mariko Inoue, Shinsuke Itoh, Iseki Takamoto, Takayoshi Sasako, Katsuyoshi Kumagai, Tomoko Kawai, Shinji Hashimoto, Tsuneo Kobayashi, Maki Sato, Kumpei Tokuyama, Satoshi Nishimura, Masaki Tsunoda, Tomohiro Ide, Koji Murakami, Tomomi Yamazaki, Osamu Ezaki, Koichi Kawamura, Hirotake Masuda, Masao Moroi, Kaoru Sugi, Yuichi Oike, Hiroaki Shimokawa, Nobuyuki Yanagihara, Masato Tsutsui, Yasuo Terauchi, Kazuyuki Tobe, Ryozo Nagai, Katsuo Kamata, Kenji Inoue, Tatsuhiko Kodama, Kohjiro Ueki, Takashi Kadowaki, Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle Cell Metabolism. ,vol. 13, pp. 294- 307 ,(2011) , 10.1016/J.CMET.2011.01.018

Curt Diehm, Jens Rainer Allenberg, David Pittrow, Matthias Mahn, Gerhart Tepohl, Roman L. Haberl, Harald Darius, Ina Burghaus, Hans Joachim Trampisch, Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease Circulation. ,vol. 120, pp. 2053- 2061 ,(2009) , 10.1161/CIRCULATIONAHA.109.865600

Michel Lièvre, Sophie Morand, Bruno Besse, Jean-Noel Fiessinger, Jean-Pierre Boissel, (BERCI) Research Group ;, Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation. ,vol. 102, pp. 426- 431 ,(2000) , 10.1161/01.CIR.102.4.426

Gerald M. Reaven, Insulin Resistance: the Link Between Obesity and Cardiovascular Disease Medical Clinics of North America. ,vol. 95, pp. 875- 892 ,(2011) , 10.1016/J.MCNA.2011.06.002

J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, , Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. ,vol. 16, pp. 434- 444 ,(1993) , 10.2337/DIACARE.16.2.434

Hideki ORIGASA, Yasuo IKEDA, Kazuyuki SHIMADA, Hiroshi SHIGEMATSU, Oral Beraprost Sodium as a Prostaglandin I2 Analogue for Vascular Events in Patients with Peripheral Arterial Disease : Meta-Analysis of Two Placebo-Controlled Randomized Trials Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku. ,vol. 9, pp. 45- 51 ,(2004) , 10.3820/JJPE1996.9.45

Jun-ichi Kawabe, Fumitaka Ushikubi, Naoyuki Hasebe, Prostacyclin in vascular diseases. - Recent insights and future perspectives -. Japanese Circulation Journal-english Edition. ,vol. 74, pp. 836- 843 ,(2010) , 10.1253/CIRCJ.CJ-10-0195

E. Selvin, A. Kottgen, J. Coresh, Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999–2002 European Heart Journal. ,vol. 30, pp. 1918- 1925 ,(2009) , 10.1093/EURHEARTJ/EHP195